Investors Snag KPTI Even Cheaper Than Its Secondary Stock Offering
March 06, 2020 at 14:34 PM EST
Looking back to 3 days ago, Karyopharm Therapeutics Inc (KPTI) priced a 6,250,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..